http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0032261-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e77f06144be4708a6ae75bd9fee56a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 1980-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f899bc1da6d0c48acf9d46414be92af |
| publicationDate | 1981-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0032261-A1 |
| titleOfInvention | Novel bis- and mono-quaternary ammonium derivatives of 2-beta, 16-beta-dipiperidino-5-alpha-androstanes, processes for their preparation and pharmaceutical preparations |
| abstract | The invention relates to novel bisquaternary ammonium derivatives of 2β, 16β-dipiperidino-5α-androstanes having the formula:n whereinn CH(CH 3 ) 2 ; R 2 = CH 3 , C 2 H 5 or CH 2 CH=CH 2 ; R 3 =CH 3 , C 2 H 5 or CH 2 CH=CH 2 , with the proviso that R 2 and R 3 are not CH 3 simultaneously; R 4 = O or H(βOR 5 ), wherein R 5 = H or aliphatic carbacyl (1-6 C); and X = a halogen atom, to processes for their preparation and to pharmaceutical preparations. The invention also relates to novel 16- monoquaternary analogs as intermediates. n The compounds possess neuromuscular blocking activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5926516-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0571012-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0571012-A3 |
| priorityDate | 1979-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.